- Home
- NPV vs PYXS Comparison
NPV vs PYXS Comparison
Compare NPV & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NPV | PYXS |
|---|---|---|
| Founded | 1993 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 71.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NPV | PYXS |
|---|---|---|
| Price | $11.04 | $1.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 38.9K | ★ 1.8M |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,820,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.92 | $0.83 |
| 52 Week High | $11.55 | $5.55 |
Technical Indicators
Market Signals| Indicator | NPV | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 36.73 | 22.91 |
| Support Level | $10.99 | $1.03 |
| Resistance Level | $11.30 | $4.58 |
| Average True Range (ATR) | 0.10 | 0.28 |
| MACD | -0.01 | -0.21 |
| Stochastic Oscillator | 13.78 | 3.52 |
Price Performance
Historical ComparisonAbout NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.